Aftercare in patients with Cushing's disease and acromegaly: Is there room for improvement?

Acta Neurochirurgica

Volumn 152, Issue 2, 2010, Pages 271-278

  Psaras, Tsambika ^a   Milian, Monika ^a   Hattermann, Valerie ^a   Gallwitz, Baptist ^a   Freiman, Thomas ^b   Honegger, Juergen ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Acromegaly; Aftercare; Cushing's disease; Medical therapy; Operative treatment; Pituitary adenoma; Radiotherapy

Indexed keywords

ANGIOPEPTIN; CABERGOLINE; DESMOPRESSIN; HYDROCORTISONE; OCTREOTIDE; PEGVISOMANT; SOMATOMEDIN C; TESTOSTERONE; THYROXINE;

ACROMEGALY; ADULT; AFTERCARE; AGED; ARTICLE; CLINICAL EVALUATION; CUSHING DISEASE; DEXAMETHASONE SUPPRESSION TEST; ENDOCRINE SURGERY; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTPATIENT DEPARTMENT; PHYSICIAN; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUESTIONNAIRE; RADIOTHERAPY; RECURRENT DISEASE; RELAPSE; REMISSION; TREATMENT DURATION;

ACROMEGALY; ADENOMA; ADULT; AFTERCARE; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ENDOCRINOLOGY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEUROSURGERY; NEUROSURGICAL PROCEDURES; OCTREOTIDE; OUTCOME ASSESSMENT (HEALTH CARE); PEPTIDES, CYCLIC; PITUITARY ACTH HYPERSECRETION; PITUITARY NEOPLASMS; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; RECURRENCE; SOMATOSTATIN;

EID: 77949268970     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-009-0544-6     Document Type: Article

References (29)

1. R Abs J Verhelst D Maiter K Van Acker F Nobels JL Coolens C Mahler A Beckers 1998 Cabergoline in the treatment of acromegaly: a study in 64 patients J Clin Endocrinol Metab 83 374 378 10.1210/jc.83.2.374 1:CAS:528: DyaK1cXhtVSnt7Y%3D 9467544 (Pubitemid 28496509)
2. G Arnaldi A Angeli AB Atkinson X Bertagna F Cavagnini GP Chrousos GA Fava JW Findling RC Gaillard AB Grossmann B Kola A Lacroix T Mancini F Mantero J Newell-Price LK Nieman N Sonino ML Vance A Giustina M Boscaro 2003 Diagnosis and complications of Cushing's syndrome: a consensus statement J Clin Endocrinol Metab 88 5593 5602 10.1210/jc.2003-030871 1:CAS:528:DC%2BD3sXhtVShu7fL 14671138 (Pubitemid 38033020)
3. J Ayuk RN Clayton G Holder MC Sheppard PM Stewart AS Bates 2004 Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentration, predict excess mortality in patients with acromegaly J Clin Endocrinol Metab 89 1613 1617 10.1210/jc.2003-031584 1:CAS:528: DC%2BD2cXjt1elsLo%3D 15070920 (Pubitemid 38507910)
4. M Bex R Abs G T'Sjoen J Mockel B Velekniers K Muermans D Maiter 2007 AcroBel- the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects J Clin Endocrinol Metab 157 399 409 1:CAS:528:DC%2BD2sXht1CmsLzL (Pubitemid 350018442)
5. BM Biller AB Grossman PM Stewart S Melmed X Bertagna J Bertherat M Buchfelder A Colao AR Hermus LJ Hofland A Klibanski A Lacroix JR Lindsay J Newell-Price LK Nieman S Petersenn N Sonino GK Stalla B Swearingen ML Vance JA Wass M Boscaro 2008 Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement J Clin Endocrinol Metab 93 2454 2462 10.1210/jc.2007-2734 1:CAS:528:DC%2BD1cXoslyktLo%3D 18413427 (Pubitemid 352008503)
6. D Bochicchio M Losa M Buchfelder 1995 Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's disease survey group J Clin Endocrinol Metab 80 3114 3120 10.1210/jc.80.11.3114 1:CAS:528:DyaK2MXptleitL4%3D 7593411
7. F Bogazzi L Battolla C Spinelli G Rossi S Gavioli V Di Bello C Cosci C Sardella D Volterrani E Talini P Pepe F Falschi G Mariani E Martino 2007 Risk factors for development of coronary heart disease in patients with acromegaly: a five-year prospective study J Clin Endocrinol Metab 92 4271 4277 10.1210/jc.2007-1213 1:CAS:528:DC%2BD2sXhtlartb3K 17785352 (Pubitemid 350080942)
8. M Boscaro L Barzon F Fallo N Sonino 2001 Cushing's syndrome Lancet 357 783 791 10.1016/S0140-6736(00)04172-6 1:STN:280:DC%2BD3M7pvVGnsA%3D%3D 11253984 (Pubitemid 32217692)
9. F Cavagnini F Pecori Giraldi 2001 Epidemiology and follow-up of Cushing's disease Ann Endocrinol (Paris) 62 168 172 1:STN:280:DC%2BD3M3ls1SqtQ%3D%3D
10. M Coculescu D Niculescu R Lichiardopol M Pureci 2007 Insulin resistance and insulin secretion in non-diabetic acromegalic patients J Clin Endocrinol Metab 115 308 316 1:CAS:528:DC%2BD2sXmt1Cjsb0%3D
11. A Colao D Ferone P Marzullo P Cappabianca S Cirillo V Boerlin I Lancranjan G Lombardi 2001 Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly J Clin Endocrinol Metab 86 2779 2786 10.1210/jc.86.6.2779 1:CAS:528: DC%2BD3MXktlKiu7c%3D 11397887 (Pubitemid 32545739)
12. A Colao R Pivonello S Spiezia A Faggiano D Ferone M Filipella P Marzullo G Cerbone M Siciliani G Lombardi 1999 Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure J Clin Endocrinol Metab 84 2664 2672 10.1210/jc.84.8.2664 1:CAS:528: DyaK1MXltFClsLY%3D 10443657
13. AF Daly M Rixhon C Adam A Dempegioti MA Tichomirova A Beckers 2006 High prevalence of pituitary adenomas: a cross-sectional study in the province of Liège, Belgium J Clin Endocrinol Metab 91 4769 4775 10.1210/jc.2006-1668 1:CAS:528:DC%2BD28XhtlGru77F 16968795 (Pubitemid 44917305)
14. MB Elamin H Murad R Mullan D Erickson K Harris S Nadeem R Ennis PJ Erwin VM Montori 2008 Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses J Clin Endocrinol Metab 93 1553 1562 10.1210/jc.2008-0139 1:CAS:528:DC%2BD1cXlvFWhu70%3D 18334594 (Pubitemid 351656487)
15. J Etxabe JA Vazquez 1994 Morbidity and mortality in Cushing's disease: An epidemiological approach Clin Endocrinol 40 479 484 10.1111/j.1365-2265.1994. tb02486.x 1:STN:280:DyaK2c3ksVSkuw%3D%3D
16. JW Findling H Raff 2006 Cushing's syndrome: important issues in diagnosis and management J Clin Endocrinol Metab 91 3746 3753 10.1210/jc.2006-0997 1:CAS:528:DC%2BD28XhtFSjtLbF 16868050 (Pubitemid 44536836)
17. PU Freda L Katznelson AJ van der Lely CM Reyes S Zhao D Rabinowitz 2005 Long-acting somatostatin analog therapy of acromegaly: a meta-analysis J Clin Endocrinol Metab 90 4465 4473 10.1210/jc.2005-0260 1:CAS:528: DC%2BD2MXnvVWltL8%3D 15886238 (Pubitemid 41159328)
18. IM Holdaway RC Rajasoorya GD Gamble 2004 Factors influencing mortality in acromegaly J Clin Endocrinol Metab 89 667 674 10.1210/jc.2003-031199 1:CAS:528:DC%2BD2cXhsFOjsLY%3D 14764779 (Pubitemid 38269875)
19. R Kauppinen-Mäkelin T Sane A Reunanen NJ Välimäki L Niskanen H Markkanen E Löyttyeniemi T Ebeling P Jaatinen H Laine P Nuutila P Salmela J Salmi UH Stenman J Viikari E Voutilainen 2005 A nationwide survey of mortality in acromegaly J Clin Endocrinol Metab 90 4081 4086 10.1210/jc.2004-1381 15886256 (Pubitemid 41058176)
20. S Melmed A Colao A Barkan M Molitch AB Grossman D Kleinberg D Clemmons P Chanson E Laws J Schlechte ML Vance K Ho A Giustina 2009 Acromegaly consensus group guidelines for acromegaly management: an update J Clin Endocrinol Metab 94 1509 1517 10.1210/jc.2008-2421 1:CAS:528:DC%2BD1MXlvVCqsbk%3D 19208732
21. A Mestrón SM Webb R Astorga P Benito M Catala S Gatzambide JM Gomez I Halperin T Lucas-Morante B Moreno G Obiols P de Pablos C Paramo A Pico E Torres C Varela JA Vasquez J Zamora M Albareda M Gilabert on behalf of all the REA participants 2004 Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA) Eur J Endocrinol 151 439 446 10.1530/eje.0.1510439 15476442 (Pubitemid 39430260)
22. L Nachtigall A Delgado B Swearingen H Lee R Zerikly A Klibanski 2008 Extensive clinical experience: changing patterns in diagnosis and therapy of acromegaly over two decades J Clin Endocrinol Metab 93 2035 2041 10.1210/jc.2007-2149 1:CAS:528:DC%2BD1cXntFamsLc%3D 18381584 (Pubitemid 351831512)
23. CB Newman S Melmed A George D Torigian M Duhaney P Snyder W Young A Klibanski ME Molitch R Gagel L Sheeler D Cook W Malarkey I Jackson ML Vance A Barkan L Frohman DL Kleinberg 1998 Octreotide as primary therapy in acromegaly J Clin Endocrinol Metab 3 3034 3040 10.1210/jc.83.9.3034 (Pubitemid 28500931)
24. AM Pereira SW van Thiel JR Lindner F Roelfsema EE van der Wall H Morreau JW Smit JA Romijn JJ Bax 2004 Increased prevalence of regurgitant valvular heart disease in acromegaly J Clin Endocrinol Metab 89 71 75 10.1210/jc.2003-030849 1:CAS:528:DC%2BD2cXmvFektA%3D%3D 14715829 (Pubitemid 38183861)
25. CM Plotz AL Knowlton C Ragan 1952 The natural history of Cushing's Syndrome Am J Med 13 597 614 10.1016/0002-9343(52)90027-2 1:STN:280: DyaG3s%2FitV2ntg%3D%3D 12996538
26. EJ Ross DC Linch 1982 Cushing's syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis Lancet 2 646 649 10.1016/S0140-6736(82)92749-0 1:STN:280:DyaL383ntV2ltg%3D%3D 6125785
27. B Swearingen FG Barker L Katznelson BMK Biller S Grinspoon A Klibanski N Moayeri P Black NT Zervas 1998 Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly J Clin Endocrinol Metab 10 3419 3426 10.1210/jc.83.10.3419 (Pubitemid 28500866)
28. B Swearingen BMK Biller FG Barker II L Katznelson S Grinspoon A Klibanski N Zervas 1999 Long-term mortality after transsphenoidal surgery for Cushing disease Ann Intern Med 130 821 824 1:STN:280:DyaK1M3kt1ajtg%3D%3D 10366371
29. AJ van der Lely RK Hutson PJ Trainer GM Besser AL Barkan L Katznelson A Klibanski V Herman-Bonert S Melmed ML Vance PU Freda PM Stewart KE Friend DR Clemmons G Johannsson S Stavrou DM Cook LS Phillips CJ Strasburger S Hackett KA Zib RJ Davis JA Scarlett MO Thorner 2001 Long-term treatment of acromegaly with pegvisomant, a growth hormone-receptor antagonist Lancet 358 1754 1759 10.1016/S0140-6736(01)06844-1 11734231 (Pubitemid 33152999)